On Thursday, April 23, 2020 at 6:00 pm ET, Emmanuel Mignot, M.D. Ph.D., Director of the Stanford Center for Sleep Sciences and Medicine spoke with Julie Flygare, J.D., President & CEO of Project Sleep, via Facebook Live for an timely discussion on narcolepsy research, immunology and treatment advancements.
Watch Now: Interview with Dr. Emmanuel Mignot, Narcolepsy Expert
Now more than ever, it is critical for researchers to better understand the connections between upper airway infections (like strep, flu, or COVID), the immune system, brain, and nervous system. During this broadcast, Dr. Emmanuel Mignot shared new advancements in our understanding of narcolepsy type 1 as a likely autoimmune disorder brought on by genetic predisposition and environmental factors like certain flu strains. Likewise, Dr. Mignot shared his perspective on COVID-19, and how narcolepsy’s connection with the H1N1 swine flu and vaccines in 2009-2010 may provide important lessons for how we manage COVID-19 and other upper airway infections and pandemics in the future.
Dr. Emmanuel Mignot and Julie Flygare also discussed:
- New and upcoming narcolepsy treatments
- Re-thinking classifications of type 2 narcolepsy and idiopathic hypersomnia
- The importance of advocacy and awareness efforts
Note: This event is for educational purposes and not intended to be a substitute for professional medical advice. Should you have personal healthcare-related questions, please contact your sleep specialist or a qualified health provider.